APPLICATION
ANDA201587
TYPE
ANDA
ORIGINAL APPROVAL
2013-01-24
LATEST ACTION
2024-07-08
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Prescription
Products
MUPIROCINPrescription
MUPIROCIN CALCIUM EQ 2% BASE · CREAM · TOPICAL
Approval history
2024-07-08Labeling · Supplement 13 · standardAP
2024-07-08Labeling · Supplement 11 · standardAP
2019-07-16Labeling · Supplement 9 · standardAP
2018-10-30Labeling · Supplement 6 · standardAP
2018-10-30Labeling · Supplement 4 · standardAP
2015-12-30Labeling · Supplement 3 · standardAP
2015-12-30Labeling · Supplement 1 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.